ArteraAI Multimodal Artificial Intelligence
Toni Choueiri, Medical Doctor and Professor at Dana-Farber Cancer Institute, congrats team ArteralAI on LinkedIn:
“Congratulations to our friends and colleagues ArteraAI their multimodal.
AI platform is revolutionary and applicable clinically.
Bravo ArteraAI team.
Read the TIME piece to get an idea about this smart company.”
Toni K. Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at DanaFarber Cancer Institute (DFCI), co-leader of the Kidney Cancer Program at DanaFarber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School. As a medical oncologist, clinical trialist, and translational researcher, he specializes in treating genitourinary cancers (prostate, bladder, testis, and kidney cancer), with a focus on kidney cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023